N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide

C26H29N5O5 — CID 143318270

IUPACN-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide
SMILESCOc1cc(Nc2ncc(-c3ccccc3N(C)C(=O)CN3CCOCC3)o2)ccc1C1=CNCO1
InChIInChI=1S/C26H29N5O5/c1-30(25(32)16-31-9-11-34-12-10-31)21-6-4-3-5-19(21)24-15-28-26(36-24)29-18-7-8-20(22(13-18)33-2)23-14-27-17-35-23/h3-8,13-15,27H,9-12,16-17H2,1-2H3,(H,28,29)
InChIKeyKPDQLERBTURNQK-UHFFFAOYSA-N
MW491.55 g/mol
LogP3.26
Rot. Bonds8

About N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide

N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide (PubChem CID 143318270) has the molecular formula C26H29N5O5 and a molecular weight of 491.55 g/mol. Its IUPAC name is N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide.

Molecular Properties

Compound NameN-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide
PubChem CID143318270
Molecular FormulaC26H29N5O5
Molecular Weight491.55 g/mol
Exact Mass491.22
IUPAC NameN-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide
SMILESCOc1cc(Nc2ncc(-c3ccccc3N(C)C(=O)CN3CCOCC3)o2)ccc1C1=CNCO1
InChIInChI=1S/C26H29N5O5/c1-30(25(32)16-31-9-11-34-12-10-31)21-6-4-3-5-19(21)24-15-28-26(36-24)29-18-7-8-20(22(13-18)33-2)23-14-27-17-35-23/h3-8,13-15,27H,9-12,16-17H2,1-2H3,(H,28,29)
InChIKeyKPDQLERBTURNQK-UHFFFAOYSA-N
XLogP3.26
TPSA101.33 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds8
Heavy Atoms36
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500491.55
LogP ≤ 53.26
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide?
The IUPAC name of N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide (CID 143318270) is N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide.
What is the SMILES notation for N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide?
The canonical SMILES for N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide is COc1cc(Nc2ncc(-c3ccccc3N(C)C(=O)CN3CCOCC3)o2)ccc1C1=CNCO1.
What is the InChIKey of N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide?
The InChIKey is KPDQLERBTURNQK-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H29N5O5/c1-30(25(32)16-31-9-11-34-12-10-31)21-6-4-3-5-19(21)24-15-28-26(36-24)29-18-7-8-20(22(13-18)33-2)23-14-27-17-35-23/h3-8,13-15,27H,9-12,16-17H2,1-2H3,(H,28,29).
What are the key properties of N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide?
N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide has a molecular weight of 491.55 g/mol, XLogP of 3.26, 8 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[2-[4-(2,3-dihydro-1,3-oxazol-5-yl)-3-methoxyanilino]-1,3-oxazol-5-yl]phenyl]-N-methyl-2-morpholin-4-ylacetamide is sourced from PubChem (CID 143318270), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).